References
- Syndman D. R., Bregman D., Bryan J. A. Hemodialysis-associated hepatitis in the United States. J Infect Dis 1974; 135: 687–691, 1977
- Stevens C. E., Harvey J. A., Taylor P. E. Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy. N Engl J Med 1984; 311: 496–501
- Meurer S. C., Köhler H., Meyer zum Büschenfelde K. H. Monocyte defect in hemodialysis patients supports nonresponsiveness to hepatitis B vaccination and development of HBsAg carrier state. Viral Hepatitis and Liver Disease, A J Zuckermann. Alan R. Liss, New York 1988; 11–23
- Nagafuchi S., Kashiwagi S., Okada K., Anzai K., Nakamura M., Nishimura Y., Sasazuki T., Niho Y. Reversal of nonresponders and postexposure prophylaxis by intradermal hepatitis B vaccination in Japanese medical personnel. J Am Med Assoc 1991; 265: 2679–2683
- Kurtz J. B., Alder M. J., Mayon-White R. T., Juel-Jensen B. E., Rodgers T. M., Babic G. M. Plasma-derived versus recombinant hepatitis B vaccines. Lancet 1989; 1: 451